For the quarter ending 2025-09-30, TCRT has $3,724K in assets. $921K in debts. $1,938K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 1,938 | 2,879 | ||
| Receivables | 0 | 2 | ||
| Prepaid expenses and other current assets, current | 747 | 857 | ||
| Total current assets | 2,685 | 3,738 | ||
| Property and equipment, net | 97 | - | ||
| Prepaid expenses and other assets, non current | 942 | 997 | ||
| Total assets | 3,724 | 4,735 | ||
| Accounts payable | 843 | 809 | ||
| Accrued expenses | 78 | 265 | ||
| Total current liabilities | 921 | 1,074 | ||
| Total liabilities | 921 | 1,074 | ||
| Preferred stock value-Series AOne Preferred Stock | 0 | 0 | ||
| Preferred stock value-Series ATwo Preferred Stock | 0 | 0 | ||
| Common stock 0.001 par value 50,000,000 shares authorized, 2,205,846 and 1,601,252 shares issued and outstanding at september 30, 2025 and at december 31, 2024, respectively | 2 | 2 | ||
| Additional paid-in capital | 926,530 | 926,229 | ||
| Accumulated deficit | -923,729 | -922,570 | ||
| Total stockholders' equity | 2,803 | 3,661 | ||
| Total liabilities and stockholders' equity | 3,724 | 4,735 | ||
Alaunos Therapeutics, Inc. (TCRT)
Alaunos Therapeutics, Inc. (TCRT)